AXGN
AXGN
NASDAQ · Health Care

Axogen Inc

$45.93
+1.70 (+3.84%)
As of Sep 21, 10:01 PM ET ·
Financial Highlights (FY 2026)
Revenue
284.84M
Net Income
-19,860,885
Gross Margin
74.3%
Profit Margin
-7.0%
Rev Growth
+17.6%
D/E Ratio
0.38
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 74.3% 74.3% 49.7% 49.7%
Operating Margin -3.5% -3.1% 10.8% 8.6%
Profit Margin -7.0% -6.6% 8.2% 9.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 284.84M 242.29M 948.34M 1.09B
Gross Profit 211.66M 180.05M 471.45M 543.24M
Operating Income -9,940,836 -7,610,371 102.11M 94.06M
Net Income -19,860,885 -15,204,828 77.32M 101.42M
Gross Margin 74.3% 74.3% 49.7% 49.7%
Operating Margin -3.5% -3.1% 10.8% 8.6%
Profit Margin -7.0% -6.6% 8.2% 9.3%
Rev Growth +17.6% +17.6% +5.7% +24.8%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 359.54M 359.54M 208.98M 163.48M
Total Equity 956.47M 956.47M 1.19B 1.27B
D/E Ratio 0.38 0.38 0.18 0.13
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -1,502,671 -1,214,305 143.45M 157.61M
Free Cash Flow 51.25M 59.12M